Clinical Trial Update: A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

This is a Phase 2a open-label randomized study evaluating the safety and efficacy of MDI-1228-mesylate gel versus standard of care in diabetic foot ulcers; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• MDI-1228-mesylate Gel (MDI-1228 mesylate gel)

Snippet

Sponsor: Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: RECRUITING